AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 66 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,281,500 | -2.1% | 550,000 | 0.0% | 0.05% | +2.2% |
Q2 2023 | $1,309,000 | +29.3% | 550,000 | 0.0% | 0.04% | +60.7% |
Q1 2023 | $1,012,000 | -3.2% | 550,000 | 0.0% | 0.03% | -9.7% |
Q4 2022 | $1,045,000 | -11.2% | 550,000 | 0.0% | 0.03% | -13.9% |
Q3 2022 | $1,177,000 | -24.4% | 550,000 | 0.0% | 0.04% | -23.4% |
Q2 2022 | $1,556,000 | -25.4% | 550,000 | +10.0% | 0.05% | -20.3% |
Q1 2022 | $2,085,000 | – | 500,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TFG Asset Management GP Ltd | 1,300,000 | $17,160,000 | 2.55% |
Alphabet Inc. | 699,352 | $9,231,000 | 0.56% |
DAFNA Capital Management LLC | 100,000 | $1,320,000 | 0.45% |
JUPITER ASSET MANAGEMENT LTD | 705,356 | $9,311,000 | 0.29% |
Artal Group S.A. | 500,000 | $6,600,000 | 0.26% |
Cormorant Asset Management, LP | 479,988 | $6,336,000 | 0.25% |
MPM BioImpact LLC | 39,740 | $525,000 | 0.19% |
Granahan Investment Management | 305,158 | $4,028,000 | 0.18% |
Burrage Capital Management LLC | 13,113 | $173,000 | 0.12% |
Vident Investment Advisory, LLC | 118,866 | $1,569,000 | 0.10% |